Fiscal Year 2012 ICD-9-CM Casefinding List: Short Version

These tables are also available in a printable version (PDF).

2012 Comprehensive ICD-9-CM Casefinding Code List for Reportable Tumors
ICD-9-CM code* Explanation of ICD-9-CM code
140._ - 172._, 174._ - 209.36, 209.7 Malignant neoplasms stated or presumed to be primary (of specified sites), and certain specified histologies
173.00, 173.09, 173.10, 173.19 Unspecified and other specified malignant neoplasm of skin of lip and eyelid, including canthus
173.20, 173.29, 173.30, 173.39 Unspecified and other specified malignant neoplasm of ear and skin of other and unspecified parts of face (Effective 10/1/2011)
173.40, 173.49, 173.50, 173.59 Unspecified and other specified malignant neoplasm of scalp and skin of neck and skin of trunk, except scrotum (Effective 10/1/2011)
173.60, 173.69, 173.70, 173.79 Unspecified and other specified malignant neoplasm of skin of upper limb, including shoulder and lower limb, including hip (Effective 10/1/2011)
173.80, 173.89, 173.90, 173.99 Unspecified and other specified malignant neoplasm of other specified sites of skin and site unspecified (Effective 10/1/2011)
225.0 - 225.9 Benign neoplasm of brain and spinal cord neoplasm
227.3, 227.4 Benign neoplasm of pituitary gland, craniopharyngeal duct (pouch) and pineal gland
228.02 Hemangioma; of intracranial structures
228.1 Lymphangioma, any site
230.0 - 234.9 Carcinoma in situ
237.0 - 237.1 Neoplasm of uncertain behavior of endocrine glands and nervous system: pituitary gland, craniopharyngeal duct and pineal gland
237.5, 237.6, 237.9 Neoplasm of uncertain behavior [borderline] of brain, spinal cord and meninges and unspecified parts of nervous system
238.4 Polycythemia vera (9950)
238.6 Plasma cells
238.7_ Other lymphatic and hematopoietic tissues
239.6, 239.7 Neoplasms of unspecified nature, brain, other parts nervous system
273.3 Macroglobulinemia
277.89 Other specified disorders of metabolism
288.4 Hemophagocytic syndrome (9751, 9754)
289.6 Familial polycythemia

Return to top

The following codes are not reportable per se, but they should alert registrars to look for the first malignant neoplasm associated with these codes.

2012 Supplementary List #1 ICD-9-CM Codes That Should Be Followed by or Associated with a Neoplasm Code
ICD-9-CM code* Explanation of ICD-9-CM code
258.0_ Polyglandular activity in multiple endocrine adenomatosis [MEN]
284.2 Myelophthisis
285.22 Anemia in neoplastic disease
289.83 Myelofibrosis (9961/3)
331.7 Cerebral degeneration in diseases classified elsewhere
336.3 Myelopathy in other diseases classified elsewhere
357.3 Polyneuropathy in malignant disease
358.1 Myasthenic syndromes in other diseases classified elsewhere
358.31 Eaton-Lambert syndrome in neoplastic disease (Effective 10/1/2011)
511.81 Malignant pleural effusion
512.82 Secondary spontaneous pneumothorax
731.1_ Osteitis deformans in diseases classified elsewhere
731.3 Major osseous defect
789.51 Malignant ascites
V07.5_ Prophylactic use of agents affecting estrogen receptors and estrogen levels
V58.42 Aftercare following surgery for neoplasm

Return to top

NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases.

2012 Supplementary List #2 ICD-9-CM Code List to Screen for Cancer Registry Cases Not Identified by Other Codes
ICD-9-CM code* Explanation of ICD-9-CM code
042 Acquired Immunodeficiency Syndrome (AIDS)
079.4, 079.5_ Human papillomavirus; Retrovirus (HTLV, types I, II and 2)
173.01, 173.02, 173.11, 173.12 Basal and squamous cell carcinoma of skin of lip and eyelid, including canthus
173.21, 173.22, 173.31, 173.32 Basal and squamous cell carcinoma of ear and skin of other and unspecified parts
173.41, 173.42, 173.51, 173.52 Basal and squamous cell carcinoma of scalp and skin of neck and skin of trunk, except scrotum
173.61, 173.62, 173.71, 173.72 Basal and squamous cell carcinoma of skin of upper limb, including shoulder and lower limb, including hip
173.81, 173.82, 173.91, 173.92 Basal and squamous cell carcinoma of other specified sites of skin and site unspecified
209.40 - 209.69 Benign carcinoid tumors
210.0 - 229.9 Benign neoplasms (except for 225.0-225.9, 227.3, 227.4, 228.02, and 228.1, which are listed in the Reportable list)
235.0 - 239.9 Neoplasms of uncertain behavior (except for 237.0, 237.1, 237.5, 237.6, 237.9, 238.4, 238.6, 238.7_, 239.6, 239.7) ,
249.20 Secondary diabetes with hypersmolarity
273.0, 273.1, 273.2, 273.8, 273.9 Disorders of plasma protein metabolism
277.88 Tumor lysis syndrome (following neoplastic chemotherapy)
279.02, 279.03, 279.05, 279.12 Select IgM immunodeficiency and other immunoglobulin deficiencies
Note: Associated with lymphoproliferative disorders
279.2, 279.3 Combined and unspecified immunity deficiency
279.41, 279.49 Autoimmune lymphoproliferative syndrome
279.50 - 279.53 Graft-versus host disease
279.8, 279.9 Other and unspecified disorders involving the immune mechanism
284.1_ Pancytopenia
284.81 - 284.9 Other and unspecified aplastic anemias
285.0 Sideroblastic anemia
285.3 Anemia due to antineoplastic chemotherapy
287.39, 287.49, 287.5 Other primary, secondary and unspecified thrombocytopenia
288.03 Drug induced neutropenia
288.3 Eosinophilia
289.89, 289.9 Other specified diseases of blood and blood forming organs
323.81 Other causes of encephalitis and encephalomyelitis
337.9 Unspecified disorders of autonomic nervous system
338.3 Neoplasm related pain (acute)(chronic)
352.9 Unspecified disorder of cranial nerves
353.8 Other nerve root and plexus disorders
516.5 Adult pulmonary Langerhans cell histiocytosis (Effective 10/1/2011)
630 Hydatidiform mole
648.9_ Other current conditions classifiable elsewhere
713.8 Arthropathy associated with other conditions classified elsewhere
728.9 Unspecified disorder of muscle, ligament, and fascia
733.1_ Pathologic fracture
758.0 Down's Syndrome
780.79 Neoplastic (malignant) related fatigue
785.6 Enlargement of lymph nodes
790.93 Elevated prostate specific antigen (PSA)
791.9 Other non specific findings on examination of urine
792.0, 792.2, 792.4, 792.9 Non specified abnormal findings in specified and unspecified body structures
793.11 Solitary pulmonary nodule (Effective 10/1/2011)
793.8_ Nonspecific (abnormal) findings on radiological and examination of body structure (breast)
795.0_, 795.1_, 795.4, 796.7_ Papanicolaou smear of cervix, vagina, anus and other with cytologic evidence of malignancy
795.8_ Abnormal tumor markers
962.1, 963.1 Poisoning by hormones ,antineoplastic, immunosuppressive drugs
990 Effects of radiation, unspecified
996.54 Mechanical complication of other specified prosthetic device, implant, and graft-due to breast prosthesis
996.85 Complication of transplanted organ
999.3_ Other infection due to central venous catheter, transfusion, infusion (Effective 10/1/2011)
E858.0 - E858.2 Accidental poisonings
E873.2 Failure in dosage, overdose of radiation in therapy
E878.0 Abnormal reaction of surgical operation with transplant of whole organ
E879.2 Overdose of radiation given during therapy
E930.7 Adverse reaction of antineoplastic therapy-Antineoplastic antibiotics
E932.1 Adverse reaction to antineoplastic therapy
E933.1 Adverse effect of immunosuppressive drugs
V10.0_ - V10.9_ Personal history of malignancy
V12.41 Personal history of benign neoplasm of the brain
V13.89 Personal history of unspecified malignant neoplasm and history of in-situ neoplasm of other site
V15.22 Personal history of undergoing in utero procedure during pregnancy
V15.3 Other personal history presenting hazards to health or radiation
V16._ Family history of malignant neoplasm
V42.81, V42.82 Organ or tissue replaced by transplants
V51.0 Encounter for breast reconstruction following mastectomy
V52.4 Fitting and adjustment of prosthetic device and implant (breast)
V54.2_ Aftercare for healing pathologic fracture
V58.0, V58.1_ Encounter for radiation, chemotherapy and immunotherapy
V66.1, V66.2, V66.7 Convalescence and palliative care
V67.1, V67.2 Follow up examinations
V71.1 Observation for suspected malignant diseases
V72.83 Other specified pre-operative examination
V76._ Special screening for malignant neoplasms
V78.8, V78.9 Other and unspecified disorders of blood and blood forming organs
V86._ Estrogen receptor status
V87.41, V87.43, V87.46 Personal history of drug therapy: antineoplastic chemotherapy, estrogen therapy and immunosuppression therapy

Return to top

The following codes are associated with the paraneoplastic syndrome. Paraneoplastic syndrome by itself is not cancer. It’s a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer. These codes have been removed from the supplemental list and are now in their own list.

ICD-9-CM Code* Explanation of ICD-9-CM Code
253.6 Syndrome of inappropriate secretion of antidiuretic hormone
259.2 Carcinoid syndrome
259.8 Other specified endocrine disorders
275.42 Hypercalcemia
379.5_ Nystagmus and other irregular eye movements
686.01 Pyoderma gangrenosum
694.4 Pemphigus
695.89 Other specified erythematous conditions
701.2 Acquired acanthosis nigricans
710.3 Dermatomyositis
710.4 Polymyositis

*International Classification of Diseases, 9th Revision, Clinical Modification, Sixth Edition (Hospital Edition), 2012

Return to top